comprehensive -WSS

comprehensive

author：explore 2025-09-28 00:51:15 - browse：2

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Biogen nominates mother of director’s child to replace him on board

WSS

Novo: Oral version of Ozempic leads to 15% weight loss

Millions may soon lose Medicaid when they don't have to

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

How to fix the rural physician shortage in the U.S.

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Sea level rise could wash away turtle breeding grounds around the world, researchers say

focus

comprehensive

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

Biogen nominates mother of director’s child to replace him on board

How to save PrEP access — and even expand it

FDA approves first new drug developed for postpartum depression

Psychedelics group wrestles with new pharma identity

Novo: Oral version of Ozempic leads to 15% weight loss

As demand for Covid shots wanes, Moderna seeks its next success

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

New air purifier tech could be key to improving indoor air quality

GSK to buy asthma

Wikipedia

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Senate panel passes drug pricing bills, but drops one PBM reform

Heart disease and mental health: A look at cardiac psychology

JPM 2024: Verve Therapeutics looks to mainstream genome editing

As JPM 2024 winds down, some health tech firms project optimism

DeSantis can now import cheaper drugs. But will Biden get credit?

Wikipedia

Wikipedia

Wikipedia

leisure time